A clinical study about contrast nephropathy: Risk factors and the role of beta blockers

OBJECTIVE: There is still a group of patient that have unpredictable risk for the development of contrast nephropathy (CN). There is also an effort to find more effficient strategies to prevent CN. Carvedilol, metoprolol and nebivolol seem to have theoretical potentials for the prevention of CN. In...

Descripción completa

Detalles Bibliográficos
Autores principales: Akgüllü, Çağdaş, Eryılmaz, Ufuk, Güngör, Hasan, Huyut, Ahmet, Zencir, Cemil, Hekim, Tolga
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kare Publishing 2015
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5337060/
https://www.ncbi.nlm.nih.gov/pubmed/25333980
http://dx.doi.org/10.5152/akd.2014.5304

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5337060/
https://www.ncbi.nlm.nih.gov/pubmed/25333980
http://dx.doi.org/10.5152/akd.2014.5304

Ejemplares similares